Explore opportunities to participate in palmoplantar keratoderma clinical trials happening in Indiana.
Palmoplantar Keratoderma (PPK) Study in Indiana
Take the next step towards participating in palmoplantar keratoderma clinical trial by completing this form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Seeking Advanced Treatment Options for Palmoplantar Keratoderma?
Palmoplantar keratoderma (PPK) is a rare genetic disorder that causes thickening of the skin on the palms of the hands and soles of the feet. This condition can lead to painful cracks, fissures, and discomfort that significantly impact daily activities and overall quality of life.
Our clinical trial is dedicated to exploring the efficacy of an innovative investigational treatment aimed at alleviating the symptoms of PPK. Participants will undergo a thorough screening process, followed by a treatment period designed to assess the drug's potential in reducing skin thickening and enhancing mobility and comfort.
Joining this clinical trial is entirely voluntary and free of charge. If you're interested in participating, please fill out the form, and a research team member will reach out to determine your eligibility for this palmoplantar keratoderma clinical trial.
Palmoplantar Keratoderma Clinical Trials in Indiana
If you or someone you know is struggling with Palmoplantar Keratoderma (PPK) and traditional treatments haven't provided relief, consider joining our clinical trial. Explore investigational therapies for PPK by enrolling in our clinical trial for palmoplantar keratoderma.
Age
18 Years and Older
Gender
Male and Female
Current Status
Recruiting
Condition
Palmoplantar Keratoderma
Location
Indianapolis
Is Palmoplantar Keratoderma Meddling with Your Routine?
Palmoplantar dermatosis is a condition characterized by abnormal thickening of the skin on the palms of the hands and the soles of the feet, leading to the formation of hard, calloused areas.
This is a condition where the skin on the palms and soles becomes thickened and calloused. In this study, participants will be given the investigational topical drug once daily for 12 weeks (about 3 months), followed by a one-week check-up. Lasting for about 17 weeks (about 4 months), this clinical trial invites participants to explore the efficacy of the investigational topical drug, potentially finding better treatment for this condition.
feature
Frequently Asked Questions
What causes Palmoplantar Keratoderma?
How do you get rid of Palmoplantar Keratoderma?
Can Keratosis be Cured?
What is the Best Treatment for Palmoplantar Keratoderma?
Who can enroll in Keratosis Clinical Trials in Indiana?
Will I be compensated for my time and travel in the Clinical Trials?
